AI assistant
ARIX BIOSCIENCE PLC Director's Dealing 2021
4968_dirs_2021-08-16_4d082f54-4cc5-487d-a93d-9b0c5820b459.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
Arix Bioscience PLC (ARIX)
Director/PDMR Shareholding
16-Aug-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Arix Bioscience plc
Director/PDMR Shareholding
Arix Bioscience plc (the "Company") today announces the annual award of nil cost options to Interim CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period, in accordance with the Company's Remuneration Policy.
| PDMR DEALING NOTIFICATION | |||
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | |||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Robert Lyne | |
| 2 | Reason for the notification | ||
| a) | Position / status | Interim Chief Executive Officer | |
| b) | Initial notification / Amendment |
Initial Notification | |
| 3 | Details of issuer | ||
| a) | Name | Arix Bioscience plc | |
| b) | LEI | 213800OVT3AHQCXNIX43 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | |
| Identification code | GB00BD045071 | ||
| b) | Nature of the transaction | Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 352,335 | ||
| d) | Aggregated information | Aggregated price | Aggregated volume |
| N/A (single transaction) | N/A (single transaction) | ||
| e) | Date of the transaction | 13 August 2021 | |
| f) | Place of the transaction | Outside a trading venue |
For further information please contact:
Optimum Strategic Communications
Mary Clark, Manel Mateus
+44 (0)20 8078 4357
- Ends -
| ISIN: | GB00BD045071 |
| Category Code: | DSH |
| TIDM: | ARIX |
| LEI Code: | 213800OVT3AHQCXNIX43 |
| OAM Categories: | 2.3. Major shareholding notifications |
| Sequence No.: | 119950 |
| EQS News ID: | 1226354 |
| End of Announcement | EQS News Service |